CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib
暂无分享,去创建一个
H. Einsele | M. Hudecek | J. Sierra | H. Bonig | W. Herr | T. Nerreter | Julian Rydzek | Simone Thomas | I. García-Cadenas | Hardikkumar Jetani | Javier Briones Meijide | J. B. Meijide